(Q36938839)

17 August 2017

Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients (English)

1 reference

17 August 2017

1 reference

1 reference

Martin Tepel

1

1 reference

17 August 2017

Werner Hopfenmueller

2

1 reference

17 August 2017

Alexandra Scholze

3

1 reference

17 August 2017

Alexandra Maier

4

1 reference

17 August 2017

Walter Zidek

5

1 reference

17 August 2017

language of work or name

English

0 references

publication date

29 May 2008

1 reference

Nephrology Dialysis Transplantation

17 August 2017

1 reference

17 August 2017

23

1 reference

17 August 2017

11

1 reference

17 August 2017

3605-3612

1 reference

Racial and survival paradoxes in chronic kidney disease

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568006

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568006

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568006

Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568006

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568006

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568006

Association of calcium channel blockers and mortality in haemodialysis patients.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568006

KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568006

High-efficiency short daily haemodialysis--morbidity and mortality rate in a long-term study.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568006

Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568006

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568006

Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568006

Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568006

Oxidative stress: does it play a role in the genesis of essential hypertension and hypertension of uraemia?

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568006

Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2568006

Calcium channel blocker use and mortality among patients with end-stage renal disease

4 September 2018

1 reference

12 December 2020

Role of systolic blood pressure in determining prognosis of hemodialyzed patients

1 reference

12 December 2020

The epidemiology of systolic blood pressure and death risk in hemodialysis patients

1 reference

12 December 2020

Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis

1 reference

12 December 2020

Identifiers

DOI

10.1093/NDT/GFN304

1 reference

release_dfui53scnnfcdm7ymrqtvzdwyu

17 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dfui53scnnfcdm7ymrqtvzdwyu

24 November 2022

mapped directly with Wikidata item

1 reference

17 August 2017

PubMed publication ID

18511605

1 reference